This HTML5 document contains 210 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n7http://dbpedia.org/resource/File:
n15https://global.dbpedia.org/id/
n13http://dbpedia.org/resource/Angiotensin_Receptor_Blockers:
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
n9http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
n13:_Drug_discovery_and_development
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
dbo:wikiPageRedirects
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Renin_inhibitor
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Eprosartan
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Losartan
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Drug_design
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Renin–angiotensin_system
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:ACE_inhibitor
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
rdf:type
dbo:Band
rdfs:label
Discovery and development of angiotensin receptor blockers
rdfs:comment
The angiotensin receptor blockers (ARBs), also called angiotensin (AT1) receptor antagonists or sartans, are a group of antihypertensive drugs that act by blocking the effects of the hormone angiotensin II (Ang II) in the body, thereby lowering blood pressure. Their structure is similar to Ang II and they bind to Ang II receptors as inhibitors, e.g., [T24 from Rhys Healthcare]. ARBs are widely used drugs in the clinical setting today, their main indications being mild to moderate hypertension, chronic heart failure, secondary stroke prevention and diabetic nephropathy.
foaf:depiction
n9:Pratosartan.svg n9:ARBdrugdevelopment.jpg n9:Renin_ang_pathway_2.jpg n9:Bindingsite.jpg
dcterms:subject
dbc:Drug_discovery dbc:Angiotensin_II_receptor_antagonists
dbo:wikiPageID
20206762
dbo:wikiPageRevisionID
1092963426
dbo:wikiPageWikiLink
dbr:Tryptophan dbr:Lipophilicity dbr:Valine dbr:Myocardial_infarction dbr:Isopropyl dbr:Homeostasis dbr:Histidine dbr:Asparagine dbr:Prodrug dbr:N-terminus dbr:Indication_(medicine) dbr:Derivative_(chemistry) dbr:Enzyme_substrate dbr:Sanofi dbr:Losartan dbr:Physiologist dbr:Tetrazole dbr:Embusartan dbr:Blood_plasma dbr:Hydrogen_bonding dbr:Blood_pressure dbr:Substituent dbr:Cardiac_contractility dbr:Heterocyclic dbr:Olmesartan dbr:Therapeutic_index dbr:Pharmacokinetic n7:Pratosartan.svg dbr:Prodrugs dbr:Novartis dbr:Chronic_heart_failure dbr:Mimic dbr:Fetus dbr:Telmisartan dbr:Diabetic_nephropathy n7:ARBdrugdevelopment.jpg dbr:CYP2C9 dbr:Renin–angiotensin–aldosterone_system dbr:Antihypertensive dbr:Ketone dbr:Aldosterone dbr:Physiological dbr:Basic_(chemistry) dbr:Bioactivity n7:Renin_ang_pathway_2.jpg dbr:Hydroxymethyl dbr:Renin dbr:Adverse_effect_(medicine) dbr:Uric_acid dbr:Phenylalanine dbr:Fonsartan dbr:Electrolyte dbr:Candesartan_cilexetil dbr:Clearance_(medicine) dbr:Angiotensinogen dbr:Half-life dbr:Chloro dbr:Receptor_antagonist dbr:Isoleucine dbr:Acetic_acid dbr:Binding_sites dbr:Angiotensin_II_receptor_type_1 dbr:Angiotensin_II_receptor_type_2 dbr:Angiotensin_receptor_blockers dbr:Biochemical dbr:Alkyl dbr:Angiotensin_converting_enzyme dbr:Angiotensin_converting_enzyme_inhibitors dbr:Angiotensin_II dbr:Transmembrane dbr:Carbonyl dbr:G-protein dbr:Irbesartan dbr:Protein dbr:Chemical_compounds dbr:Hydrogen_bond dbr:Saralasin dbr:Carbonate dbr:Blood–brain_barrier dbr:Candesartan dbr:Tyrosine dbr:Salt_bridge_(protein_and_supramolecular) dbr:Cytochrome_P450 dbc:Drug_discovery dbr:Stroke dbr:Boehringer_Ingelheim dbr:Mechanism_of_action dbr:Daiichi_Sankyo_Co. dbr:Angiotensin_receptor dbr:Angiotensin_I dbr:Angiotensin_II_receptor_antagonist dbr:Alanine dbr:Lipid_metabolism dbr:Functional_groups dbr:Placebos dbr:G-proteins dbr:Bioavailable dbr:Benzyl dbr:Ester dbr:Renal dbr:Merck_&_Co. dbr:Carboxylic_acid dbr:Gastrointestinal_tract dbr:Bioavailability dbr:Ion dbr:Metabolite dbr:Hydrolyzed dbr:Enzyme dbr:Peptide dbr:Intracellular dbr:In_vivo dbr:Carboxyl dbr:Captopril dbr:Absorption_(pharmacokinetics) dbr:Helices dbr:G_protein-coupled_receptor dbr:Intravenously dbr:Imidazoles dbr:Hypertension dbr:Molecular_modeling dbr:G_protein-coupled_receptors dbr:Biphenyl dbr:Pratosartan dbr:Glucose_metabolism n7:Bindingsite.jpg dbr:Concentration dbr:Lysine dbc:Angiotensin_II_receptor_antagonists dbr:Esterases dbr:Ischaemic dbr:Vasopressin dbr:Hydrophilicity dbr:Amino_acid dbr:Hypothesis dbr:Amino_acids dbr:Chemical_polarity dbr:Vasoconstriction dbr:Adrenal_glands dbr:Valsartan dbr:Nuclear_magnetic_resonance dbr:Serine dbr:Hydrophobic dbr:Lipophilic dbr:Benzimidazole dbr:Discovery_and_development_of_renin_inhibitors dbr:Clinical_trials dbr:Phenol dbr:Acidic dbr:Hormone dbr:Takeda_Pharmaceutical_Company dbr:Methyl dbr:Ligand_(biochemistry) dbr:Renin–angiotensin_system dbr:SmithKline_Beecham dbr:Rational_drug_design dbr:ACE_inhibitors dbr:DuPont dbr:Acyl dbr:Partial_agonist dbr:Aspartic_acid dbr:ACE_inhibitor dbr:Phenyl dbr:C-terminal dbr:Angiotensin_II_antagonist dbr:Eprosartan dbr:Olmesartan_medoxomil dbr:Extracellular dbr:Pharmacophore dbr:Potency_(pharmacology) dbr:Robert_Tigerstedt dbr:Arginine dbr:Glucuronidation dbr:Sodium_reabsorption
owl:sameAs
n15:4ipgr freebase:m.04yft37 wikidata:Q5281995
dbp:wikiPageUsesTemplate
dbt:Short_description dbt:Angiotensin_receptor_modulators dbt:Drug_design dbt:Reflist
dbo:thumbnail
n9:Bindingsite.jpg?width=300
dbo:abstract
The angiotensin receptor blockers (ARBs), also called angiotensin (AT1) receptor antagonists or sartans, are a group of antihypertensive drugs that act by blocking the effects of the hormone angiotensin II (Ang II) in the body, thereby lowering blood pressure. Their structure is similar to Ang II and they bind to Ang II receptors as inhibitors, e.g., [T24 from Rhys Healthcare]. ARBs are widely used drugs in the clinical setting today, their main indications being mild to moderate hypertension, chronic heart failure, secondary stroke prevention and diabetic nephropathy. The discovery and development of ARBs is a demonstrative example of modern rational drug design and how design can be used to gain further knowledge of physiological systems, in this case, the characterization of the subtypes of Ang II receptors.
gold:hypernym
dbr:Group
prov:wasDerivedFrom
wikipedia-en:Discovery_and_development_of_angiotensin_receptor_blockers?oldid=1092963426&ns=0
dbo:wikiPageLength
34962
foaf:isPrimaryTopicOf
wikipedia-en:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Discovery_and_development_of_beta-blockers
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Forasartan
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
dbr:Discovery_and_development_of_Angiotensin_Receptor_Blockers
dbo:wikiPageWikiLink
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
dbo:wikiPageRedirects
dbr:Discovery_and_development_of_angiotensin_receptor_blockers
Subject Item
wikipedia-en:Discovery_and_development_of_angiotensin_receptor_blockers
foaf:primaryTopic
dbr:Discovery_and_development_of_angiotensin_receptor_blockers